{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

New MSIF Japanese website

MSIF is delighted to announce the launch of the new Japanese-language version of our website.

The site is a translation of core content of the English version of our website and includes basic information about symptoms, diagnosis and treatments of multiple sclerosis as well as MS society contact details and other useful resources in Japanese.

Please click here to go to the new site.

MSIF's 2006 Annual Review now available

MSIF's Annual Review for 2006 is now available in print and online.

read more

Do you use our My World of MS online community?

If so, have your say on its future development by taking part in our new survey.

read more

back to top

Profile of the Month : January 2008

Erlend Berntsen

Age: 27
Country: Norway
Occupation: Admissions Officer
Year of diagnosis: 2000

"I’ve tried to maintain my hopes and dreams for the future."

English Italiano Espanol Deutsch Francais Russian

read more

back to top

Interferon-beta therapy reduces CD4(+) and CD8(+) T-cell reactivity in multiple sclerosis

The authors looked at the mechanism of action of interferon-beta in preventing relapses in MS. They found that it may work via a reduction in the number of immune cells in the bloodstream which are activated against the external layer of the neurons.

authors: Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M.

source: Immunology. 2007 May;121(1):29-39

read more

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

This study found that higher disability in people with MS was associated with reduced sun exposure and therefore also low vitamin D levels.

authors: van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ.

source: J Neurol. 2007 Apr 11

read more

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

The authors looked at antibodies directed against interferon-beta and found that their presence reduced the levels of markers of its biological efficacy in people with MS on treatment.

authors: Scagnolari C, Duda P, Bagnato F, De Vito G, Alberelli A, Lavolpe V, Girardi E, Durastanti V, Trojano M, Kappos L, Antonelli G.

source: J Neurol. 2007 Apr 10

read more

Involvement of morbilliviruses in the pathogenesis of demyelinating disease

The authors looked at the possible role of some viruses, from the morbillivirus family, in the pathogenesis of various diseases which affect the central nervous system in the same manner as MS.

authors: Sips GJ, Chesik D, Glazenburg L, Wilschut J, De Keyser J, Wilczak N.

source: Rev Med Virol. 2007 Apr 5

read more

back to top

Canadian MS Society updates FAQs about Tysabri

source: MS Society of Canada

The MS Society of Canada has recently updated the frequently asked questions about Tysabri on their website.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.